Klaus Früh, Ph.D.
Oregon Health Sciences University
“New Vaccine Strategies Using Cytomegalovirus”
Tuesday, November 6
143 Jones Building
Host: Bryan Cullen
Dr. Klaus Früh has spent a considerable part of his career defining how human CMV blocks various antiviral pathogens in order to establish long-term, chronic infections. More recently, he has used this knowledge to develop human CMV as a platform for the induction of long-term immune responses that can effectively protect against other pathogenic viruses. This work will be the focus of this seminar.